The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tadalafil 20mg film-coated tablets

Brillpharma (Ireland) LimitedPA22749/020/004

Main Information

Trade NameTadalafil 20mg film-coated tablets
Active SubstancesTadalafil
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/020/004

Group Information

ATC CodeG04BE Drugs used in erectile dysfunction
G04BE08 tadalafil


License statusAuthorised
Licence Issued12/05/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back